Innate immune dysfunction in HIV infection: Effect of HIV envelope-NK cell interactions

Journal of Immunology

Volumn 176, Issue 2, 2006, Pages 1107-1114

  Kottilil, Shyam ^a   Shin, Kyungmin ^a   Jackson, Julia O ^a   Reitano, Kristin N ^a   O'Shea, Marie Angeline ^a   Yang, Jun ^b   Hallahan, Claire W ^a   Lempicki, Richard ^b   Arthos, James ^a   Fauci, Anthony S ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CHEMOKINE; CELL SURFACE RECEPTOR; CHEMOKINE RECEPTOR CCR5; GAMMA INTERFERON; GLYCOPROTEIN GP 120;

APOPTOSIS; ARTICLE; CELL FUNCTION; CELL INTERACTION; CELL PROLIFERATION; CELL SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DNA MICROARRAY; DOWN REGULATION; EXPOSURE; GENE CONTROL; HOST RESISTANCE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE SYSTEM; INFECTION SENSITIVITY; MICROARRAY ANALYSIS; NATURAL KILLER CELL; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; VALIDATION PROCESS; VIREMIA; VIRUS ENVELOPE;

EID: 30744446711     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.176.2.1107     Document Type: Article

References (43)

1. Lanier, L. L. 2001. On guard-activating NK cell receptors. Nat. Immunol. 2: 23-27.
2. Trinchieri, G. 1989. Biology of natural killer cells. Adv. Immunol. 47: 187-376.
3. Moretta, A., C. Bottino, M. Vitale, D. Pende, R. Biassoni, M. C. Mingari, and L. Moretta. 1996. Receptors for HLA class-I molecules in human natural killer cells. Annu. Rev. Immunol. 14: 619-648.
4. Lanier, L. L., and J. H. Phillips. 1996. Inhibitory MHC class 1 receptors on NK cells and T cells. Immunol. Today 17: 86-91.
5. Barao, I., and J. L. Ascensao. 1998. Human natural killer cells. Arch. Immunol. Ther. Exp. 46: 213-229.
6. Kottilil, S., T. W. Chun, S. Moir, S. Liu, M. McLaughlin, C. W. Hallahan, F. Maldarelli, L. Corey, and A. S. Fauci. 2003. Innate immunity in human immunodeficiency virus infection: effect of viremia on natural killer cell function. J. Infect. Dis. 187: 1038-1045.
7. Mavilio, D., J. Benjamin, M. Daucher, G. Lombardo, S. Kottilil, M. A. Planta, E. Marcenaro, C. Bottino, L. Moretta, A. Moretta, and A. S. Fauci. 2003. Natural killer cells in HIV-1 infection: dichotomous effects of viremia on inhibitory and activating receptors and their functional correlates. Proc. Natl. Acad. Sci. USA 100: 15011-15016.
8. + T cells by macrophage-tropic HIV envelope. J. Immunol. 163: 420-426.
9. + T cells. Proc. Natl. Acad. Sci. USA 97: 1178-1183.
10. Cicala, C., J. Arthos, S. M. Selig, G. Dennis, Jr., D. A. Hosack, D. Van Ryk, M. L. Spangler, T. D. Steenbeke, P. Khazanie, N. Gupta, et al. 2002. HIV envelope induces a cascade of cell signals in non-proliferating target cells that favor virus replication. Proc. Natl. Acad. Sci. USA 99: 9380-9385.
11. Arthos, J., A. Rubbert, R. L. Rabin, C. Cicala, E. Machado, K. Wildt, M. Hanbach, T. D. Steenbeke, R. Swofford, J. M. Farber, and A. S. Fauci. 2000. CCR5 signal transduction in macrophages by human immunodeficiency virus and simian immunodeficiency virus envelopes. J. Virol. 74: 6418-6424.
12. Kornfeld, H., W. W. Cruikshank, S. W. Pyle, J. S. Berman, and D. M. Center. 1988. Lymphocyte activation by HIV-1 envelope glycoprotein. Nature 335: 445-448.
13. Weissman, D., R. L. Rabin, J. Arthos, A. Rubbert, M. Dybul, R. Swofford, S. Venkatesan, J. M. Farber, and A. S. Fauci. 1997. Macrophage-tropic HIV and SIV envelope proteins induce a signal through the CCR5 chemokine receptor. Nature 389: 981-985.
14. lck in human CD4 T lymphocytes. Eur. J. Immunol. 23: 600-607.
15. Briant, L., N. Coudronniere, V. Robert-Hebmann, M. Benkirane, and C. Devaux. 1996. Binding of HIV-1 virions or gp120-anti-gp120 immune complexes to HIV-1-infected quiescent peripheral blood mononuclear cells reveals latent infection. J. Immunol. 156: 3994-4004.
16. Banda, N. K., J. Bernier, D. K. Kurahara, R. Kurrle, N. Haigwood, R. P. Sekaly, and T. H. Finkel. 1992. Crosslinking CD4 by human immunodeficiency virus gp120 primes T cells for activation-induced apoptosis. J. Exp. Med. 176: 1099-1106.
17. Chirmule, N., and S. Pahwa. 1996. Envelope glycoproteins of human immunodeficiency virus type 1: profound influences on immune functions. Microbiol. Rev. 60: 386-406.
18. Cauda, R., M. Tumbarello, L. Ortona, P. Kanda, R. C. Kennedy, and T. C. Chanh. 1988. Inhibition of normal human natural killer cell activity by human immunodeficiency virus synthetic transmembrane peptides. Cell. Immunol. 115: 57-65.
19. Peruzzi, M., C. Azzari, M. E. Rossi, M. De Martino, and A. Vierucci. 2000. Inhibition of natural killer cell cytotoxicity and interferon γ production by the envelope protein of HIV and prevention by vasoactive intestinal peptide. AIDS Res. Hum. Retroviruses 16: 1067-1073.
20. Nair, M. P., and S. A. Schwartz. 1997. Inhibition of natural killer cell activities from normal donors and AIDS patients by envelope peptides from human immunodeficiency virus type I. Cell. Mol. Biol. 43: 969-979.
21. Nair, M. P., and S. A. Schwartz. 2000. Reversal of human immunodeficiency virus type 1 protein-induced inhibition of natural killer cell activity by α interferon and interleukin-2. Clin. Diagn. Lab. Immunol. 7: 101-105.
22. + T cells. Genome Res. 11: 1198-1204.
23. Geiss, G. K., R. E. Bumgarner, M. C. An, M. B. Agy, A. B. van 't Wout, E. Hammersmark, V. S. Carter, D. Upchurch, J. I. Mullins, and M. G. Katze. 2000. Large-scale monitoring of host cell gene expression during HIV-1 infection using cDNA microarrays. Virology 266: 8-16.
24. Kottilil, S., K. Shin, M. Planta, M. McLaughlin, C. W. Hallahan, M. Ghany, T. W. Chun, M. C. Sneller, and A. S. Fauci. 2004. Expression of chemokine and inhibitory receptors on natural killer cells: effect of immune activation and HIV viremia. J. Infect. Dis. 189: 1193-1198.
25. Oh, S. K., W. W. Cruikshank, J. Raina, G. C. Blanchard, W. H. Adler, J. Walker, and H. Kornfeld. 1992. Identification of HIV-1 envelope glycoprotein in the serum of AIDS and ARC patients. J. Acquir. Immune Defic. Syndr. 5: 251-256.
26. Tusher, V. G., R. Tibshirani, and G. Chu. 2001. Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl. Acad. Sci. USA 98: 5116-5121.
27. Castriconi, R., C. Cantoni, M. Della Chiesa, M. Vitale, E. Marcenaro, R. Conte, R. Biassoni, C. Bottino, L. Moretta, and A. Moretta. 2003. Transforming growth factor β 1 inhibits expression of NKp30 and NKG2D receptors: consequences for the NK-mediated killing of dendritic cells. Proc. Natl. Acad. Sci. USA 100: 4120-4125.
28. + natural killer (NK) cells: a highly dysfunctional NK subset expanded in HIV-infected viremic individuals. Proc. Natl. Acad. Sci. USA 102: 2286-2291.
29. De Maria, A., M. Fogli, P. Costa, G. Murdaca, F. Puppo, D. Mavilio, A. Moretta, and L. Moretta. 2003. The impaired NK cell cytolytic function in viremic HIV-1 infection is associated with a reduced surface expression of natural cytotoxicity receptors (NKp46, NKp30 and NKp44). Eur. J. Immunol. 33: 2410-2418.
30. Oliva, A., A. L. Kinter, M. Vaccarezza, A. Rubbert, A. Catanzaro, S. Moir, J. Monaco, L. Ehler, S. Mizell, R. Jackson, et al. 1998. Natural killer cells from human immunodeficiency virus (HIV)-infected individuals are an important source of CC-chemokines and suppress HIV-1 entry and replication in vitro. J. Clin. Invest. 102: 223-231.
31. + T cells in viremic versus aviremic HIV-infected individuals. Proc. Natl. Acad. Sci. USA 100: 1908-1913.
32. Kim, S. Y., J. Li, G. Bentsman, A. I. Brooks, and D. J. Volsky. 2004. Microarray analysis of changes in cellular gene expression induced by productive infection of primary human astrocytes: implications for HAD. J. Neuroimmunol. 157: 17-26.
33. Moir, S., A. Malaspina, O. K. Pickeral, E. T. Donoghue, J. Vasquez, N. J. Miller, S. R. Krishnan, M. A. Planta, J. F. Turney, J. S. Justement, et al. 2004. Decreased survival of B cells of HIV-viremic patients mediated by altered expression of receptors of the TNF superfamily. J. Exp. Med. 200: 587-599.
34. Wang, Z., G. Trillo-Pazos, S. Y. Kim, M. Canki, S. Morgello, L. R. Sharer, H. A. Gelbard, Z. Z. Su, D. C. Kang, A. I. Brooks, et al. 2004. Effects of human immunodeficiency virus type 1 on astrocyte gene expression and function: potential role in neuropathogenesis. J. Neurovirol 10(Suppl. 1): 25-32.
35. + patients produce C-C chemokines and inhibit HIV-1 infection. J. Immunol. 161: 6433-6438.
36. Alkhatib, G., C. Combadiere, C. C. Broder, Y. Feng, P. E. Kennedy, P. M. Murphy, and E. A. Berger. 1996. CC CKR5: a RANTES, MIP-1α, MIP-1β receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 272: 1955-1958.
37. Arthos, J., C. Cicala, S. M. Selig, A. A. White, H. M. Ravindranath, D. Van Ryk, T. D. Steenbeke, E. Machado, P. Khazanie, M. S. Hanback, et al. 2002. The role of the CD4 receptor versus HIV coreceptors in envelope-mediated apoptosis in peripheral blood mononuclear cells. Virology 292: 98-106.
38. Moore, J. P., A. Trkola, and T. Dragic. 1997. Co-receptors for HIV-1 entry. Curr. Opin. Immunol. 9: 551-562.
39. Feng, Y., C. C. Broder, P. E. Kennedy, and E. A. Berger. 1996. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 272: 872-877.
40. Brenner, B. G., A. Dascal, R. G. Margolese, and M. A. Wainberg. 1989. Natural killer cell function in patients with acquired immunodeficiency syndrome and related diseases. J. Leukocyte Biol. 46: 75-83.
41. Geijtenbeek, T. B., D. S. Kwon, R. Torensma, S. J. van Vliet, G. C. van Duijnhoven, J. Middel, I. L. Cornelissen, H. S. Nottet, V. N. KewalRamani, D. R. Littman, et al. 2000. DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell 100: 587-597.
42. Janvier, K., C. Petit, E. Le Rouzic, O. Schwartz, and S. Benichou. 2000. HIV auxiliary proteins: an interface between the virus and the host. AIDS 14(Suppl. 3): S21-S30.
43. Stevenson, M. 2003. HIV-1 pathogenesis. Nat. Med. 9: 853-860.